You have 9 free searches left this month | for more free features.

Busulfan

Showing 1 - 25 of 765

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Busulfan Sample Collection Study

Not yet recruiting
  • Subjects Treated With Busulfan
  • MyCare Oncology Busulfan Assay Kit
  • (no location specified)
Jan 25, 2023

Myeloid Malignancies Trial in Chendu (fractionated busulfan-based conditioning regimen)

Recruiting
  • Myeloid Malignancies
  • fractionated busulfan-based conditioning regimen
  • Chendu, Sichuan, China
    West China Hospital, Sichuan University
Mar 29, 2023

Acute Myeloid Leukemia, MDS Trial in China (Fludarabine, busulfan and melphalan, Fludarabine and Busulfan)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Fludarabine, busulfan and melphalan
  • Fludarabine and Busulfan
  • Fuzhou, Fujian, China
  • +8 more
Aug 14, 2023

Blood Samples to Identify Biomarkers of Busulfan

Active, not recruiting
  • Leukemia
  • +4 more
    • Seattle, Washington
      University of Washington
    Jan 4, 2023

    Myeloid Malignancies, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial in Hackensack (Fludarabine and Busulfan

    Active, not recruiting
    • Myeloid Malignancies
    • +4 more
    • Fludarabine and Busulfan plus/minus Total Body Irradiation (low dose)
    • Fludarabine and Busulfan + Low Dose Total Body Irradiation (LD TBI)
    • Hackensack, New Jersey
      John Theurer Cancer Center at Hackensack University Medical Cent
    Feb 25, 2022

    Leukemia, Acute Lymphoblastic, Myeloid Leukemia, Acute, Biphenotypic Acute Leukemia Trial in Saint Petersburg (Fludarabine,

    Recruiting
    • Leukemia, Acute Lymphoblastic
    • +5 more
    • Saint Petersburg, Russian Federation
      RM Gorbacheva Research Institute
    Jul 19, 2022

    Severe Combined Immune Deficiency (SCID) Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)

    Enrolling by invitation
    • Severe Combined Immune Deficiency (SCID)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 24, 2022

    Cancer Trial in Jinan (Busulfan, Paclitaxel, Afatinib, Ceritinib, Crizotinib (Antineoplastic drugs))

    Recruiting
    • Cancer
    • Busulfan, Paclitaxel, Afatinib, Ceritinib, Crizotinib (Antineoplastic drugs)
    • Jinan, Shandong, China
      Shandong Provincial Qianfoshan Hospital
    Jul 18, 2022

    Hematopoietic Stem Cell Transplantation, Malignant Hematological Diseases Trial in Suzhou (Umbilical Cord Blood Transplantation)

    Recruiting
    • Hematopoietic Stem Cell Transplantation
    • Malignant Hematological Diseases
    • Umbilical Cord Blood Transplantation
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow university
    Jul 3, 2023

    Acute Myeloid Leukemia, Adult, Myelodysplastic Syndrome(MDS), Allogeneic Hematopoietic Stem Cell Transplantation Trial in Wuhan

    Recruiting
    • Acute Myeloid Leukemia, Adult
    • +2 more
    • Fludarabine and Busulfan
    • Fludarabine and Melphalan
    • Wuhan, Hubei, China
      Wuhan Union Hospital, Tongji Medical college, Huazhong Universit
    Jan 5, 2023

    Acute Myeloid Leukemia, Pediatric Cancer Trial in Boston (Uproleselan, Fludarabine, Clofarabine)

    Recruiting
    • Acute Myeloid Leukemia
    • Pediatric Cancer
    • Boston, Massachusetts
    • +1 more
    Oct 24, 2022

    Acute Leukemia Trial in Suzhou (mitoxantrone liposome, ATG)

    Recruiting
    • Acute Leukemia
    • mitoxantrone liposome
    • ATG
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Feb 13, 2023

    Chronic Granulomatous Disease Trial run by the NIAID (Sirolimus, Cyclophosphamide, Alemtuzumab)

    Recruiting
    • Chronic Granulomatous Disease
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jul 23, 2022

    Severe Aplastic Anemia Trial (Busulfan, Flu/Cy/ATG or Cy/ATG)

    Not yet recruiting
    • Severe Aplastic Anemia
    • Busulfan
    • Flu/Cy/ATG or Cy/ATG
    • (no location specified)
    Oct 1, 2023

    Hematopoietic Malignancy, Relapse/Recurrence, Hematopoietic Stem Cell Transplantation Trial in Suzhou (Umbilical Cord Blood

    Recruiting
    • Hematopoietic Malignancy
    • +2 more
    • Umbilical Cord Blood Transplantation
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow university
    Nov 6, 2023

    T-cell Non-Hodgkin Lymphoma Trial in Boston (Cyclophosphamide, Doxorubicin, Vincristine)

    Terminated
    • T-cell Non-Hodgkin Lymphoma
    • Boston, Massachusetts
    • +1 more
    Jan 26, 2023

    Hematologic Malignancies Trial in New York (Busulfan 3.2 mg/kg/day, Fludarabine, Melphalan)

    Recruiting
    • Hematologic Malignancies
    • Busulfan 3.2 mg/kg/day
    • +5 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Mar 14, 2022

    Cytarabine+Thiotepa + Fludarabine + Busulfan, T Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Trial in Hangzhou

    Recruiting
    • Cytarabine+Thiotepa + Fludarabine + Busulfan
    • T Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
    • cytarabine+thiotepa+ fludarabine + busulfan
    • Hangzhou, China
      The First Affiliated Hospital, College of Medicine, Zhejiang Uni
    Oct 26, 2022

    T-cell Non-Hodgkin Lymphoma, Lymphoma, Extranodal NK-T-Cell Trial in Busan, Daegu (Busulfan, Fludarabine)

    Recruiting
    • T-cell Non-Hodgkin Lymphoma
    • Lymphoma, Extranodal NK-T-Cell
    • Busan, Korea, Republic of
    • +1 more
    Aug 17, 2022

    Haploidentical Stem Cell Transplantation, Conditioning Trial in Xi'an (MA-BUCY2, BUCY2)

    Not yet recruiting
    • Haploidentical Stem Cell Transplantation
    • Conditioning
    • Xi'an, Shaanxi, China
      First Affiliated Hospital of Xian Jiaotong University
    Apr 14, 2023

    Intravenous Busulfan And Fludarabine Myeloablative Conditioning

    Completed
    • Acute Myeloid Leukemia
    • +3 more
      • (no location specified)
      Mar 16, 2022

      Acute Myeloid Leukemia in Remission Trial in France (Fludarabine, Busulfan, ATG)

      Not yet recruiting
      • Acute Myeloid Leukemia in Remission
      • Nantes, Loire Atlantique, France
      • +22 more
      Jun 15, 2023

      Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Immune System Diseases Trial run by the NCI (drug, radiation,

      Recruiting
      • Lymphoproliferative Disorders
      • +4 more
      • Busulfan test dose
      • +8 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 23, 2023

      Leukemia Trial (biological, drug, procedure, radiation)

      Active, not recruiting
      • Leukemia
      • aldesleukin
      • +9 more
      • (no location specified)
      Feb 17, 2022

      Leukemia, MDS Trial (drug, procedure, radiation)

      Active, not recruiting
      • Leukemia
      • Myelodysplastic Syndromes
      • busulfan
      • +7 more
      • (no location specified)
      Feb 17, 2022